The live cell encapsulation market offers key opportunities in regenerative medicine, drug delivery, and chronic disease management, driven by advancements in biomaterials and biotechnology. With a ...
SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing ...
LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
In 2020, there were 2.3 million women diagnosed with breast cancer. Deaths related to cancer occur due to metastasis. In most types of solid tumors, spreading happens through collective migration, ...
A cell is fundamentally a container—a vessel that encapsulates life at the most basic level. Many biologists believe encapsulation of chemicals may have been necessary for evolution to gain traction.
Encellin Inc. has announced the closing of a US$9.9 million financing round that will support the company’s development of its cell encapsulation platform with an initial focus on type 1 diabetes.
Scientists have created SpudCell, a synthetic cell assembled entirely from non-living materials that can grow, copy DNA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results